STEM CELL TRANSPLANT COMPLICATIONS
Clinical trials for STEM CELL TRANSPLANT COMPLICATIONS explained in plain language.
Never miss a new study
Get alerted when new STEM CELL TRANSPLANT COMPLICATIONS trials appear
Sign up with your email to follow new studies for STEM CELL TRANSPLANT COMPLICATIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to keep leukemia away after transplant
Disease control Not yet recruitingThis study tests a new oral drug called revumenib in people with acute myeloid leukemia (AML) who have certain genetic changes. After a stem cell transplant, participants will take revumenib or a placebo to see if it helps keep the cancer from coming back. The trial involves 144 …
Matched conditions: STEM CELL TRANSPLANT COMPLICATIONS
Phase: PHASE2 • Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New drug combo aims to make dual transplants safer for kidney and blood cancer patients
Disease control Not yet recruitingThis early-phase study tests whether adding the drug venetoclax to standard transplant preparation is safe for people with chronic kidney disease and a blood cancer. Only 3 adults aged 18-70 will take part. The goal is to see if the combination helps the new stem cells and kidney…
Matched conditions: STEM CELL TRANSPLANT COMPLICATIONS
Phase: EARLY_PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC